Reg A+ Direct to Nasdaq: A New Path to the Public Markets

June 13, 2023

On May 18, 2023, Monogram Orthopaedics—a cutting-edge medtech company revolutionizing joint replacement surgery—achieved the ultimate goal so many startups aspire to: listing on the Nasdaq.

Going public is widely considered to be the pinnacle of success for a business. Not only does it allow companies to raise capital from a much broader audience... it also lends a great deal of credibility and validation to the companies themselves.

Why Companies Choose Reg A+ Path to Nasdaq

Community Building

Reg A+ allows companies to convert customers into shareholders and shareholders into customers.

Marketing Flexibility

Less restrictive marketing rules compared to traditional S-1 filings, allowing general solicitation.

Founder Control

Founders maintain control over deal terms and valuation, regardless of market conditions.

Less Regulatory Burden

Provides exemptions from certain reporting and disclosure obligations under the Securities Act.

This is an incredibly exciting next step for Monogram Orthopaedics and for other companies that are still earlier in their journeys, it’s an excellent demonstration of a unique new way to reach the public markets: by starting with a Reg A raise.

Only a handful of companies have taken this route so far, but we may see that trend increase.

Here’s why:

Equity crowdfunding builds community—and that means momentum

When you do an S-1, you have to go into a quiet period. It's very constrictive in terms of what you can do and how you communicate. That doesn't work in the modern world, where everyone uses Facebook and Instagram and communicates in real time.

Industry Expert Perspective

According to Mark Elenowitz, community-building—and the momentum it generates—is the main reason companies choose to use Reg A+ as a stepping stone to a public listing. It's an effective way to convert customers into shareholders and shareholders into customers.

Reg A allows the ability to market and use general solicitation with modern techniques. Companies still disclose all risk factors and provide investors with the information needed to make informed decisions, but deliver it in a new and modern way.

Those same leads and Reg A+ investors become an engaged community of followers and fans that are ready and excited to buy shares post-listing—driving significant early momentum when the company goes public.

It’s easier and cheaper than a traditional IPO

Reg A+ offers a scaled-down version of the regulatory requirements compared to a traditional IPO. It provides exemptions from certain reporting and disclosure obligations under the Securities Act of 1933, making it less burdensome in terms of compliance and ongoing regulatory obligations.

Companies that raise capital via Reg A+ can more or less use the raise as a springboard to a public exchange; it’s a way for them to access capital and generate interest while they go through the lengthy process of filing for a public listing.

Venture deals are smaller and harder to come by

Current Fundraising Landscape

According to Carta data from Q1 2023, compared to Q1 2022:

3.5×
More Down Rounds
Down rounds increased significantly year-over-year in early 2023
20%
Of All Funding Rounds
Nearly a fifth of all funding rounds were down rounds in Q1 2023
15.6%
Participating Preferred Stock
Up from just 6.5% in Q1 2022, indicating investor-favorable terms
Growth in Online Capital Raising
While VC deals declined, equity crowdfunding showed steady YoY growth

By raising capital online, founders can avoid the "Valley of Death," offer shares to their communities, and set their own deal terms (including valuation, share type, and more).

Founders that raise from their communities get to stay in the driver's seat and maintain control. They can set the terms of their offering without the pressure of the current market conditions.

Founders using Reg A+ can set their own terms

VC deals aren’t just fewer and farther between than usual… they're also happening on heavily investor-favored terms. Deals offering participating preferred stock jumped to a whopping 15.6% in Q1 2023 (compare that to just 6.5% in Q1 2022).

All these factors combined create a very tough funding climate for startups seeking capital. They also create an exciting opportunity for equity crowdfunding to bridge the gap.

Founders that raise from their communities get to stay in the driver's seat... meaning they can set the terms of their offering without the pressure of the current market conditions. That means they can choose to issue non-voting shares and even have the final say on their valuation.

So what does the future hold for this pathway to the public markets? Mark says that while adoption is currently increasing, we likely need a major household name company to take the lead before this model really takes off.

Of course, for companies of that size, the real value of a Reg A+ raise is the brand-building aspect of it. These are massive, VC-backed unicorns we’re talking about; they don’t need to raise money from the crowd in order to keep growing. Still, it would be an incredibly powerful community-building play, breaking down barriers for their customers and fans to share in the success of the company.

“The industry just needs to find a company that can do it right. If Instacart decided to use a Reg A—that would really accelerate adoption of the model,” he said. “If an Instacart, a Canva, a Stripe-sized company did a Reg A, we’d see a much higher acceptance level. The model works; we just need the right candidates to use it.”

LEARN MORE » Watch a replay of our recent webinar, “Path To Going Public: Reg A To Nasdaq IPO”

Monogram Case Study - DealMaker (Embed)

When VCs said no, Monogram turned to retail investors. That decision powered their rise from startup to publicly traded company—and even helped them raise an additional $13M privately after their Nasdaq debut.

Monogram at NASDAQ celebration

The Challenge: Raising Capital on Their Terms

The Challenge: Raising on Their Terms

Monogram Technologies was founded with a bold vision: to revolutionize orthopedic surgery with a robotic joint replacement system using custom 3D-printed joints. The market for this technology is massive—approximately $19.6 billion, with over 1 million knee replacements per year. But it's a capital-intensive, regulation-heavy space—and traditional VCs weren't biting.

Instead of compromising, co-founders Dr. Doug Unis and Ben Sexson went all-in on a different path: retail capital. Why?

  • Control and ownership: Not only were they able to raise the capital they needed to grow the business—they did it on their own terms.
  • Long-term asset: They wanted to build an army of true believers who wanted to see the company succeed and would continue to reinvest over the years.
  • A value-add network: Raising from retail allowed Monogram to amass a waiting list of thousands of patients eager to participate in future trials.
  • Aligned incentives: Their mission to improve patient outcomes and build a better future for those struggling with joint pain resonated with retail investors.

The Power of Retail: Monogram's Capital Journey

Start Date End Date Type Platform Amount Raised # Investors
3/13/193/31/20A+SeedInvest$14,588,6686,000
11/16/201/16/21A+StartEngine$2,965,5018,000
1/17/212/18/22A+StartEngine$23,647,85314,082
7/15/223/16/23CFDealMaker$4,673,0002,249
3/1/234/8/23A+Republic$232,275120
3/1/235/23/23A+DealMaker$15,958,3645,198
5/18/23-Nasdaq listing
7/2410/24Unit OfferingDealMaker$12,990,1032,745

Monogram Capital Raise Timeline

Monogram's first direct-to-investor raise was a $14.6M round in 2019. Since then, Monogram has raised retail capital six additional times, using Reg A+ as a springboard to a Nasdaq listing in 2023.

Each raise brought in new believers—and more importantly, kept bringing them back. That's the long-term power of retail capital. It's not just one campaign—it's a compounding asset that grows with the business.

$80M+
Raised across seven campaigns
~40,000
Investors championing Monogram's vision
20%
Of each raise came from previous investors

Marketing Excellence

DealMaker Reach provided strategic investor acquisition services, helping Monogram connect with the right audience through high-impact channels.

Premium Publications

Targeted campaigns in premium publications like Morning Brew captured qualified investors

High-Engagement Webinars

Engaging events that generated over $4.3 million in investments

Community Building

Strategic approaches that fostered a loyal shareholder base

Investment Momentum

Innovative approaches that amplified investment momentum

Monogram's Journey to Success

Monogram's journey has been defined by relentless innovation, strategic fundraising, and breakthrough advancements in robotic-assisted joint replacement. From early-stage research to a Nasdaq listing and beyond, Monogram's milestones reflect its evolution into a pioneering force in orthopedic surgery:

  • Filed its first patent application in 2017
  • Conducted clinical studies at UCLA and University of Nebraska
  • Expanded the team with key hires
  • Attracted a top-tier advisory board to guide clinical innovations
  • Signed their first distribution partnerships
  • Made headlines with cutting-edge live demonstrations
  • Secured 501(k) FDA clearance for the mBôs surgical system

Nasdaq Debut & Beyond

In May 2023, Monogram Orthopaedics successfully listed on the Nasdaq—a significant milestone offering liquidity and growth opportunities for the company.

For most companies, that would be the end of their story in the private markets. But for Monogram, it was just the beginning of a new chapter.

Public perception says you can't raise privately post-IPO. Monogram proved that wrong.

Defying conventional fundraising norms, Monogram raised an additional $13 million from private investors, powered by DealMaker. This move highlighted the power of a dedicated investor community and provided additional strategic growth capital. Meanwhile, strategic digital marketing for the private offering helped boost the public share price—a win-win for the company and its investors, both public and private.

This was retail capital at its best: strategic, repeatable, and aligned.

One vision. Zero compromises.

This wasn't a one-time raise. It was a multi-year capital strategy.

Retail capital helped Monogram:

  • Go from concept to commercialization without relying on VCs
  • Retain ownership and control in a high-burn industry
  • Build a base of loyal shareholders who invested not once, but over and over again
  • Uplist to the Nasdaq, and still keep raising post-IPO

This is what makes retail capital different. It doesn't expire—it compounds. And DealMaker is built to maximize that long-term value.

Dr. Doug Unis Quote
Ben Sexson Quote

Ready to Raise Capital on Your Terms?

Whether you're pre-revenue or post-IPO, DealMaker gives you the infrastructure, support, and strategy to raise from the people who believe in you most.

Explore Raising Capital with DealMaker
DealMaker Logo

The ultimate technology for raising capital online

Talk to the experts
The ultimate technology for raising capital online - talk to the experts